Stemtech (STEK) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access STEK Annual Cash Flow →
The table below presents a historical view of Stemtech's cash flow activity, supporting analysis of liquidity trends over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1.45
Depreciation & amortization0.08
Amortization of Other Assets0.01
Increase (Decrease) in Deferred Revenue-0.17
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.09
R & D, Environmental and Other Expense0.00
Gain (Loss) on Sale of Assets and Asset Impairment Charges0.00
Share-based Compensation0.51
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.12
Finance Lease Right Of Use Asset Amortization-
Derivative Gain Loss On Derivative Net-
Noncash Interest Expense From Issuance On Debt Derivative-
Stock Issued To Vendor For Services-
Operating Lease Right Of Use Asset Amortization Expense-
Amortization Due To Conversionredemptions-
Amortization Of Right Of Use Asset-
Operating Lease Liabilities-
Cancellation Of Shares Returned By Shareholders-
Derivative Gain On Derivative-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Accounts Receivable-0.02
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.51
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.05
Discontinued operations0.00
Net Cash flow from Operating Activities-0.48
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.31
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.23
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.05
Shares Subscribed Not Issued-
Interest-
Cash Received In Recapitalization Transaction-
Proceeds From Factoring Liability-
Repayment Of Debt-
Repayment Of Note Payable And Factoring Liability-
Net Proceeds From Factoring Arrangement0.08
Payments On Factoring Arrangements-
Net Proceeds From Financing Arrangement-
Net Repayments Proceeds From Factoring Arrangement-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.18
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.48
Total Cash Flow0.01
4 historic quarters locked

Sign in to unlock the full Stemtech cash flow history.

About Stemtech Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-26-006490

Figures are derived from filed reports and may be restated. Historical data is subject to revision.